Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT06078436
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 160 participants
- Sponsor
- Min-Seok Kim
- Registry
-
NCT06078436
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT06078436. Randomized; no masking; primary purpose treatment. Start 2024-01 (anticipated); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF
- Acronym
- PACE-SHOCK
- Condition
- Cardiogenic Shock
- Intervention (Device)
- Pulmonary artery catheter
- Lead sponsor
- Min-Seok Kim
Record details
- Record id
cardio:ct-nct06078436- Content hash
2124617bc320e742c3988413efbf3545e1c9924b669c41442a11057424b6075d